Amneal Pharmaceuticals, Inc. (NYSE: AMRX) is an integrated specialty pharmaceutical company powered by a robust U.S. generics business and a growing branded business. Together, our team is working to build one of the most dynamic pharmaceutical companies in our rapidly changing industry. Today’s healthcare environment requires a new approach and new ideas. While staying true to our reputation for quality, service and value, we are reinventing our processes, our playbook and our creative partnerships. We are focused on delivering outcomes that meet important medical needs, make quality medicines more accessible and more affordable, and provide solutions for tomorrow’s health challenges. Amneal was founded in 2002 by Chirag and Chintu Patel, who continue to guide Amneal as Co-CEOs. Chirag and Chintu's vision for founding Amneal was inspired by their father, Kanu Patel, an industrial pharmacist who worked as a pharmaceutical regulatory inspector in India.